New program launches to train NJ community college students for gene therapy jobs
Johnson & Johnson is contributing $1 million to support the development of curricula and modernization of training and lab ...
News Medical on MSN20h
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments
MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...